News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Week in Review: Mindray Medical Buys U.S. Ultrasound Company for $105 Million



6/17/2013 8:27:43 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

June 15, 2013 -- Mindray Medical will pay $105 million to acquire Zonare Medical Systems, a California high-end ultrasound device maker; Simcere Pharma announced a third drug development collaboration with Bristol-Myers Squibb for a biologic arthritis treatment; Jiangsu Chia-tai Tianqing Pharma in-licensed China rights to a hepatitis C drug from an Israeli company, BioLineRx; Alliance Boots, the UK drug wholesaler and pharmacy chain, wants to do deals with China partners to expand its presence there; FortuneRock, a Beijing startup, sold non-exclusive US rights for neutropenia drug technology to an unnamed global top 10 pharma; and GlaxoSmithKline fired its head of China R&D after a journal article published by members of its China R&D staff was found to contain misrepresentations. More details….

Stock Symbols: (NYSE: MR) (NYSE: SCR) (NYSE: BMY) (NSDQ: BLRX); TASE: BLRX) (NYSE: GSK)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES